Portuguese regulator completes Granules plant re-inspection
New Delhi : Drug firm Granules India said re-inspection of its manufacturing facility at Gagillapur in Telangana has been successfully completed by Portugal's health authority INFARMED.
Last month, Granules said it had received 11 observations from INFARMED for its Gagillapur facility. INFARMED had conducted a renewal inspection of the facility.
"After submission of the responses to the audit observation, re-inspection of the said facility was conducted by INFARMED from January 31 to February 2. We are pleased to inform that re-inspection was completed successfully," Granules India said in a regulatory filing.
The plant manufactures pharmaceutical formulation intermediates (PFIs) and finished dosages.
Shares of Granules India were trading 7.10 per cent higher at Rs 124.50 apiece on the BSE.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd